Fig. 1. HepG2 cell viability by ma-huang extract.
Fig. 2. LDH release of HepG2 cells by ma-huang extract.
Fig. 3. IL-8 secretion of HepG2 cells by ma-huang extract.
Fig. 4. M-CSF secretion of HepG2 cells by ma-huang extract.
Fig. 5. Lipid accumulation of HepG2 cells by amiodarone (A) or ma-huang extract (B).
Fig. 6. Confocal imaging of nile red binding in HepG2 cells after exposure to control (A), amiodarone (B) or ma-huang extract (C).
References
- Bajaj J1, Knox JF, Komorowski R, Saeian K. The irony of herbal hepatitis: Ma-Huang-induced hepatotoxicity associated with compound heterozygosity for hereditary hemochromatosis. Dig. Dis. Sci. 48: 1925-1928 (2003) https://doi.org/10.1023/A:1026105917735
- Bjornsson E. Drug-induced liver injury: Hy's rule revisited. Clin. Pharmacol. Ther. 79: 521-528 (2006) https://doi.org/10.1016/j.clpt.2006.02.012
- Browning JD, Horton JD. Molecular Mediators of Hepatic Steatosis and Liver Injury. J. Clin. Invest. 114: 147-152 (2004) https://doi.org/10.1172/JCI200422422
- Elewa H, Abd-Elmeneem M, Hashem AM, Alshehaby A. Study of interleukin 8 (IL8) serum level in patients with chronic liver disease due to hepatitis C virus (HCV) with and without hepatocellular carcinoma (HCC). Int. J. of Hepatol. 1: 9-17 (2010)
- Esterbauer H, Schaur RJ, Zollner H. Chemistry and Biochemistry of 4-Hydroxynonenal, Malonaldehyde and Related Aldehydes. Free Radic. Biol. Med. 11: 81-128 (1991) https://doi.org/10.1016/0891-5849(91)90192-6
- Estes JD, Stolpman D, Olyaei A, Corless CL, Ham JM, Schwartz JM, Orloff SL. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch. Surg. 138: 852-858 (2003) https://doi.org/10.1001/archsurg.138.8.852
- Gutierrez-Ruiz MC, Gomez Quiroz LE, Hernandez E, Bucio L, Souza V, Llorente L, Kershenobich D. Cytokine response and oxidative stress produced by ethanol, acetaldehyde and endotoxin treatment in HepG2 cells. Isr. Med. Assoc. J. 3: 131-136 (2001)
- Huang YS, Hwang SJ, Chan CY, Wu JC, Chao Y, Chang FY, Lee SD. Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study. Zhonghua Yi Xue Za Zhi 62: 327-333 (1999)
- Itoh Y, Okanoue T, Enjyo F, Sakamoto S, Ohmoto Y, Hirai Y, Kagawa K, Kashima K. Serum levels of macrophage colony stimulating factor (M-CSF) in Liver Disease. J. Hepatol. 21: 527-535 (1994) https://doi.org/10.1016/S0168-8278(94)80097-9
- Lee MK, Cheng BW, Che CT, Hsieh DP. Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation. Toxicol. Sci. 56: 424-430 (2000) https://doi.org/10.1093/toxsci/56.2.424
- Nadir A, Agrawal S, King PD, Marshall JB. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am. J. Gastroenterol. 91: 1436-1438 (1996)
- Shaw D. Toxicological risks of Chinese herbs. Planta. Med. 76: 2012-2018 (2010) https://doi.org/10.1055/s-0030-1250533
- Skoulidis F, Alexander GJ, Davies SE. Ma huang associated acute liver failure requiring liver transplantation. Eur. J. Gastroenterol. Hepatol. 17: 581-584 (2005) https://doi.org/10.1097/00042737-200505000-00017
- Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J. Hepatol. 43: 901-910 (2005) https://doi.org/10.1016/j.jhep.2005.08.002
- Watkins PB, Seeff LB. Drug-induced liver injury: Summary of a single topic clinical research conference. Hepatology 43: 618-631 (2006) https://doi.org/10.1002/hep.21095
- Zhu Y, Li YG, Wang JB, Liu SH, Wang LF, Zhao YL, Bai YF, Wang ZX, Li JY, Xiao XH. Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China. Gut. Liver 9: 525-533 (2015) https://doi.org/10.5009/gnl14184
- Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C, Tacke F. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One 6: e21381 (2011) https://doi.org/10.1371/journal.pone.0021381